Robert Eugene Kristal, Chief Financial Officer at BioRestorative Therapies, Inc. (BRTX), bought 200 shares at $4.56 ($912) on 2022-06-07, disclosed to the SEC on 2022-06-07.
Open-market purchase of $912 BRTX by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |